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ABSTRACT
In 2018, 34.2 million Americans had diabetes and there continues to be 1.5 million Americans
diagnosed with diabetes every year (ADA, 2018). Due to this increasing prevalence, selfmanagement of type 2 diabetes mellitus (T2DM) is essential to disease management. The
PICOT question for this project was: In adults with T2DM with a hemoglobin A1C (HbA1C)
greater than 8% in a diabetes specialty clinic (P), what is the effect of a multimodal smartphone
application (I) compared to prior nonuse of the application (C) on average blood glucose
readings (O) over an 8-week period (T)? The project was completed in a large, metropolitan
area located in southcentral Wisconsin. There was a total of 11 participants, comprised mostly
of males with a range from 46-76 years of age. The Johns Hopkins Nursing Evidence-Based
Practice (JHNEBP) Model was utilized to guide the development and implementation of this
project. The project used a within-group design that evaluated the effect of a multimodal
smartphone application on average blood glucose levels. Data were collected through patientowned glucometers that were connected via Bluetooth to the mySugr© application. Preintervention and post-intervention blood glucose level data were analyzed using a paired
sample t-test. Secondary outcomes included time in range (TIR), estimated HbA1C, and DESSF scores. Statistically significant differences were found for average blood glucose levels (p =
.008), TIR (p = .0025), estimated HbA1C (p = .00048), and DES-SF scores (p =.007). Findings
from this project demonstrated that the use of a multimodal smartphone application can lower
average blood glucose levels.
Keywords: type 2 diabetes mellitus, blood glucose, self-management, smart phone
application
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CHAPTER 1
INTRODUCTION
Background
Chronic disease in the United States affects six in ten adults and costs $3.8 trillion in
annual health care costs (CDC, 2021). The key lifestyle risk factors for chronic disease include
tobacco use, poor nutrition, lack of physical activity, and excessive alcohol use (CDC, 2021). The
top seven leading chronic diseases include heart disease, cancer, chronic lung disease, stroke,
Alzheimer’s disease, diabetes, and chronic kidney disease (CDC, 2021). With diabetes being
one of the leading chronic diseases in the United States, disease management is essential. In
2018, 34.2 million Americans had diabetes and there are 1.5 million Americans diagnosed with
diabetes every year (ADA, 2018). Diabetes was the seventh leading cause of death in the United
States in 2017 and may even be underreported as a cause of death (ADA, 2018). Type 2
diabetes mellitus (T2DM) specifically comprises 90-95% of persons with diabetes mellitus (CDC,
2019).
T2DM requires lifelong management and has been known to be challenging for patients
to regulate. Self-management is one of the main goals of treatment and is essential for the
management of the disease. Due to the many complications resulting from T2DM, glycemic
control is one of the most important goals of management (Lizarondo, 2021). Diabetes selfmanagement education is a crucial part of successful disease management and can assist
people with T2DM feel more confident with knowledge of their chronic illness (Pal et al., 2013).
T2DM usually affects people over the age of 45 years but is becoming more and more
prominent in children and young adults (CDC, 2019). With T2DM, the cells in the body do not
respond normally to insulin that is produced by the pancreas, causing the pancreas to secrete
more insulin in an attempt to regulate the glucose in the blood (CDC, 2019). Over time, the
pancreas cannot keep up with the rising levels of glucose in the blood and the high levels of
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glucose eventually lead to T2DM (CDC, 2019). T2DM also affects the ability of the body to
metabolize carbohydrates, fats, and proteins (Pal et al., 2013). The disease can lead to many
systemic health complications, such as diabetic ketoacidosis; neuropathy; skin and eye
complications; foot complications; nephropathy; and cardiovascular disease (ADA, 2018). With
its many possible complications, T2DM can be extremely difficult to effectively manage and
poses many challenges for patients with the diagnosis. Because of the complexity of T2DM, the
topic has been heavily researched in an attempt to find effective ways to implement lifestyle
changes and effectively manage the disease.
The purpose of this evidence-based practice (EBP) project is to implement the identified
best practice for improving self-efficacy behaviors and perceptions, average blood glucose
levels, and time in range in adult patients with T2DM. The clinical question being addressed is
“What is the best practice for adults with T2DM to improve average glycemic control, and selfefficacy?” The secondary clinical question is “What is the effect of a diabetes-specific multimodal
smart phone application on self-efficacy behaviors and perceptions, glycolate hemoglobin A1c
(HbA1C) levels, and blood glucose levels?”
Data Supporting Need for the Project
Global, National, Regional, and State Data
T2DM is becoming more and more prevalent across the world. The World Health
Organization (WHO) acknowledged that globally, the prevalence of people living with diabetes
rose from 108 million in 1980 to 422 million in 2014 (WHO, 2021). The WHO also reports that 1.5
million deaths were directly caused by diabetes (WHO, 2019). The WHO reports that adults with
diabetes have a two-to-three-fold increased risk of heart attacks and strokes (WHO, 2021). The
United States also struggles with T2DM management and reports that 10.8% of Americans are
living with T2DM (America’s Health Rankings, 2021). Specifically in Wisconsin, the state ranks
below the national average in terms of percent of people living with T2DM but does rank 8th in the
nation with 8.7% of the population living with diabetes (America’s Health Rankings, 2021).
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Because of the increasing prevalence of T2DM in Wisconsin, the cost of diabetes-related care is
$5.5 billion each year (ADA, 2018). It is important to note that an estimated 30,000 people in
Wisconsin are newly diagnosed with T2DM each year (ADA, 2018). The prevalence of this
disease, as well as its self-management challenges, pose and support the clinical question and
warrants further investigation with the proposed project.
The project site is a clinic located within Dane County in south central Wisconsin. The
county houses 546,695 people with 5.4% of the population being veterans who would access the
project site for health care (Healthy Dane, 2019). White, non-Hispanic persons comprise 79.2%
of the population, 5.5% are Black or African American, and 6.3% are Asian (Healthy Dane,
2019). Black and Hispanic persons’ death rate related to complications of diabetes are more than
two times higher than that of their white counter parts in Dane county (Healthy Dane
Collaborative, 2018). The clinic is in a stable socioeconomic area where 95.8% of the population
aged 25 years or older have a high school degree or higher, 51.4% of the population 25 years or
older have a bachelor’s degree or higher, and the mean household income in this county is
$73,893 (Healthy Dane, 2019). In Dane county, 95.1% of people also do have some form of
health insurance compared to the other counties in the state that average 93.5% of people
(Healthy Dane, 2019). In Dane County alone, diabetes complications account for 12.8 per 10,000
hospitalizations in persons 18 years or older (Healthy Dane Collaborative, 2018).
Clinical Agency Data
This project is a pilot T2DM management project aimed at reducing average blood
glucose readings and in turn reducing HbA1C levels. The clinic where the project will take place
is in a moderate-size, metropolitan area in south central Wisconsin. The area is located is a
stable socioeconomical location. All patients who attend this clinic are either active service
military members or retired military service members. Since the project site is part of a national
health care system that is commonly known, patients travel from all over the state of Wisconsin
to come to this clinic to receive their care. Of note, because of the COVID-19 pandemic, many in-
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person appointments have been changed to telehealth visits related to travel restrictions and the
health care system’s ability to maintain telehealth for patients. Because of the COVID-19
pandemic, the health care system has increased its use of MyHealtheVet; an online
communication tool that increases communication opportunities between patients and providers.
This communication tool can help patients with prescription refills, viewing their appointments,
secure messaging with providers and clinic staff, and viewing test results or medical records
(Rohrer, 2020). At the project site, 50% of patients are already registered for this feature and
15% are actively using secure messaging with their providers (Rohrer, 2020).
The patient population attending the health care facility totals 169,574 (National Center
for Veterans Analysis and Statistics, 2017). Greater than 30% of patients that receive care at the
project site are over the age of 65 years. Nearly 40% of patients receiving care at the project site
have a median income of $50,000 to $99,000 per year (National Center for Veterans Analysis
and Statistics, 2017). The patient population receiving care at the project site is mainly
comprised of males (National Center for Veterans Analysis and Statistics, 2017).
The project site is known for its research and up-to-date practice policies. The site prides
itself on significantly contributing to advancements in health care for veterans and other
Americans from every walk of life (U.S. Department of Veteran Affairs, 2021). The proposed
doctor of nursing practice (DNP) project was developed in conjunction with the nurse practitioner
who is employed at the project site. There are also providers who work in conjunction with the
nurse practitioner who have also acknowledged that the use of the application could aid in the
self-management of T2DM.
Discussion with the nurse practitioner who is assisting the student project leader in this
program revealed that the goal for HbA1C levels for majority of the patients at the project site is
7.5% (J. Phelan, personal communication, July 26, 2021). After a review of the electronic
medical record software used at the project site, it was determined that the clinic treats well over
200 patients and manages patients with type 1 diabetes mellitus (T1DM) and T2DM. For the
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purpose of this project, only the patients with T2DM will be eligible for participation. The clinic
staff acknowledged that many patients do not check their blood glucose as they are advised;
they feel there is no point or feel that their provider is not actually looking at glucose readings (J.
Phelan, personal communication, July 26, 2021).
The need for this project was discussed at length with the nurse practitioner at the project
site. Current patients that do not use the application are responsible for driving themselves to
clinic appointments, bringing their current glucose meter to each appointment and having their
meter downloaded when in the clinic. This allows the provider to view the trends of the patient’s
blood glucose readings, but appointment time is spent looking over glucose readings during the
actual appointment. If the application was used and patients are able to upload a generated
portable document format (PDF) report of blood glucose readings, the provider would be able to
review readings before the appointment and appointments would be more time efficient.
The application that is proposed for use in this project is already available to all patients
that receive care at the project site. The nurse practitioner acknowledges that there are many
barriers to implementation of the application use for patients. Barriers include but are not limited
to; many patients do not know about the application, patients not knowing how to properly use it
or connect it to their glucose meter, or inconsistency of checking blood glucose because they
view it as pointless (J. Phelan, personal communication, July 28, 2021). Each patient at the
project site is provided with a glucose meter and the instruction manual includes instructions on
application use. Not many patients actually read the instruction manual, resulting in low uptake
and low knowledge of the application (J. Phelan, personal communication, July 28, 2021). On
occasion, some patients will forget to bring their meter to their appointment which makes it very
difficult to make necessary changes to a patient’s management plan (J. Phelan, personal
communication, July 28, 2021). The use of the application could ease patient burden for
transporting their meter to all appointments and increase time in care management or care
adjustment at each appointment.
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Purpose of the Evidence-Based Practice Project
Purpose Statement and PICOT Question
The purpose of this EBP project is to determine if implementation of identified best
practice in a diabetes specialty clinic will result in lower average blood glucose readings for
patients with T2DM resulting in lower HbA1C levels. Specifically, this project will address the
following PICOT question: In adults with type 2 diabetes mellitus with a HbA1C greater than 8%
in a diabetes specialty clinic (P), what is the effect of a multimodal smartphone application (I)
compared to prior nonuse of the application (C) on average blood glucose readings (O) over an
8-week period (T)?
EBP Project Description
The proposed project will include the implementation of a multimodal, diabetes-specific
mobile phone application and the evaluation of its effect on average blood glucose levels, TIR,
and patient’s self-efficacy of disease management. Participants will be recruited via retrospective
chart review and recruited if they have a HbA1C greater than 8%, have T2DM, have a smart
phone or tablet, are 18 years or older, and are English speaking. The project will be implemented
by the student project leader, a nurse practitioner, a clinic nurse, and a clinical pharmacist. At the
start of the project, participants will evaluate their self-efficacy through the Diabetes
Empowerment Scale- Short Form (DES-SF) (Appendix I) and their last HbA1C level will be
retrieved by the student project leader via chart review. Permission to utilize the DES-SF was
granted by the Michigan Diabetes Research Center (Appendix H). The application that will be
utilized for the project will be mySugr©. This application will be available to each participant that
has an Accu-Chek Guide Me© glucose meter, which the project site supplies for participants.
There will be an initial visit with each participant once consent is obtained to explain the goals of
the project and how the project will be implemented. The project duration will be 8-weeks and
each participant will be contacted weekly or biweekly via phone call or video chat to discuss any
problems, concerns, or questions. The participants will be given the option of how frequently they
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would like to be contacted throughout the 8-week duration of the project. Also, during the weekly
or biweekly meetings, participants will be asked to upload their blood glucose report readings
into the MyHealtheVet system for review by their health care provider and the student project
leader. At the completion of the 8-week project, participants average blood glucose levels and
time-in-range will be evaluated by the student project leader, participants will complete another
DES-SF (Appendix I) and fill out a project satisfaction survey (Appendix D). The student project
leader will then analyze the data and disseminate the findings with key stakeholders, the project
site evidence-based practice coordinators, participants, and Valparaiso University.
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CHAPTER 2
EBP MODEL AND REVIEW OF LITERATURE
Evidence-based Practice Model
Overview of EBP Model
EBP is an essential competency for all healthcare professionals and fosters an
environment of change (Dang & Dearholt, 2018). Dang & Dearholt (2019) define EBP as “a
problem-solving approach to clinical decision-making within a healthcare organization” (p. 4).
The EBP model chosen to guide this project is the Johns Hopkins Nursing Evidence-Based
Practice Model (JHNEBP). The JHNEBP model was developed by a combination of nurses and
faculty from Johns Hopkins University School of Nursing who desired to create a way to
transition EBP into nursing practice (Melnyk & Fineout-Overholt, 2019). This model is initiated
with a team’s curiosity about best practices related to a specific problem or clinical area (Melnyk
& Fineout-Overholt, 2019). After the clinical problem has been identified, the practice question,
evidence, and translation (PET) process begins. Within the PET process, there are a total of 18
steps that are followed to guide the project. In the practice question step, there are five steps that
include: Recruitment of interprofessional team, development and refining the EBP question,
defining the scope of the EBP question and identification of stakeholders, determining
responsibility for project leadership, and scheduling of team meetings (Melnyk & FineoutOverholt, 2019). The evidence step consists of five more steps, including: Conducting internal
and external searches for evidence, appraising the level and quality of each piece of evidence,
summarizing the individual evidence, synthesizing overall strength and quality of evidence, and
developing recommendations for change based on evidence synthesis (Melnyk & FineoutOverholt, 2019). The final step of the JHNEBP model is translation, which includes the last eight
steps: Determining fit, feasibility, and appropriateness of recommendations for translation path;
creating an action plan; securing support and resources to implement action plan; implementing
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action plan; evaluating outcomes; reporting outcomes to stakeholders; identifying next steps; and
dissemination of findings (Melnyk & Fineout-Overholt, 2019). With the utilization of the PET
process, the project is planned, completed, and findings are shared at its completion.
The JHNEBP model was chosen for this project because of the versatility of the model.
The model can be used by an individual or by a group, which allows it to be used in many
different settings. The PET process allows for organization of the project and gives the project
facilitator a guide for best practice searching, implementation, and sharing the findings of the
project.
Literature Search
Sources Examined for Relevant Evidence
An exhaustive search of the literature was performed by the student project leader and
included searches from Joanna Briggs Institute (JBI), Cochrane Library, Turning Research into
Practice (TRIP), Cumulative Index to Nursing and Allied Health Literature (CINAHL), MEDLINE,
Pubmed, and PsycInfo. A further hand-search of the literature was performed and included
searches in the Journal of Medical Internet Research (JMIR), The United States Preventative
Services Task Force (USPSTF) website, and the American Diabetes Association (ADA) website.
A PRISMA chart was created by the student project leader and is available for reference within
this paper. The key words used in a variety of different searches included: “Diabetes mellitus”,
“type 2”, diabetes, self-manag*, “lifestyle modification”, “hemoglobin A1c”, and adult*. Many
different combinations of the key words were used to result in a final, best search of the
literature. The different combinations of the key words were also used to narrow the literature
search in the databases listed above. Different limiters were used in the different databases to
limit the search to relevant literature. Limiters included the year range from 2013-2021, scholarly
peer-reviewed articles, United States clinical practice guidelines, and the English language. The
Research Services Librarian from Valparaiso University was involved in assisting in the
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determination of a systematic search and helped determine that a successful exhaustion of the
literature was achieved.
After an exhaustive search within each database, 105 articles were identified for
screening based on their title. After these were identified, inclusion and exclusion criteria were
created to narrow the search further. Articles that were excluded included those with patient
populations including type 1 diabetes mellitus or gestational diabetes mellitus, pediatric
populations, and those that included insulin pumps or continuous glucose monitors. These
factors do not meet the goals of this project; therefore, they were excluded. With the application
of the exclusion criteria and abstract screening, 84 articles were excluded from the literature
search. The remaining 22 articles were retrieved and fully examined by the student project
leader. As a result of this full examination, additional articles were identified as not acceptable for
inclusion. The final literature synthesis consisted of 14 articles from a variety of databases listed
below in Figure 2.1.
Figure 2.1
Literature Search
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Levels of Evidence
The tool used for leveling of the evidence was the Melnyk and Fineout-Overholt (2019)
hierarchy of evidence. Using this hierarchy system allows the student project leader to evaluate
the reliability of the chosen pieces of evidence. The evidence hierarchy provides guidance with
VII different levels of evidence, with level I being the highest, and level VII being the lowest level.
The higher the level of evidence within the hierarchy, the more confident the reader can be about
having similar health outcomes in similar patient populations (Melnyk & Fineout-Overholt, 2019).
The evidence utilized in this project consists of three evidence summaries, eight systematic
reviews, one meta-analysis, one clinical practice guideline, and one randomized controlled trial
(RCT). After evaluation of each piece of evidence using the above tool, it was determined that 13
pieces of evidence were level I and one piece of evidence was determined to be level II. Table
2.1 provides the specific level determined for each piece of evidence chosen for inclusion in this
project.
Analysis and Appraisal of Relevant Evidence
After an exhaustive search of the literature, 14 pieces of evidence were utilized to
determine best practice for self-management of T2DM. Each piece of evidence was evaluated
for level and strength or quality of the evidence (Appendix L) The Critical Appraisal Skills
Programme (CASP) tool and the Appraisal of Guidelines Research and Evaluation (AGREE II)
instrument were used to evaluate the evidence. The CASP tool, a formal tool for evaluation of
systematic reviews and RCTs, was chosen for its effectiveness and ease-of-use. The AGREE II
tool was used in the appraisal of the clinical practice guideline (CPG) from 2017. This tool was
chosen because it can be applied to all types of CPGs (Schmidt & Brown, 2019). With the
utilization of the CASP and AGREE II tools, there were 12 pieces of evidence that were
determined to be strong quality, the CPG was determined to be excellent, and the RCT was
determined to be good quality (Table 2.1). Table 2.1 provides a summary of the literature that
was chosen for utilization in this project and includes the databases where they were found, the
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level and type of evidence, the quality, and the tool used to evaluate them. The majority of the
evidence utilized in this EBP project consisted of systematic reviews, as this level of evidence
has been considered the heart of EBP for some time now (Melnyk & Fineout-Overholt, 2019).
For this reason, other pieces of evidence determined to be of good quality were excluded.
Table 2.1
Summary of Evidence

Author/yr

Database(s)

Level of
Evidence/Type

Quality/Tool

Minoee (2021)

JBI

I/Summary

Strong/CASP

Manuel (2020)

JBI

I/Summary

Strong/CASP

Lizarondo (2021)

JBI

I/Summary

Strong/CASP

Alexandre (2021)

JBI

I/SR

Strong/CASP

I/SR

Strong/ CASP

I/CPG

Excellent/AGREE II

Pal et al. (2013)
VA/DoD

Cochrane
TRIP

Aminuddin et al. (2019)

CINAHL

I/SR

Strong/CASP

Wang et al. (2019)

CINAHL

II/RCT

Good/ CASP

Yoshida et al. (2018)

CINAHL

I/Meta-analysis.

Strong/CASP

Cai et al. (2019)

Medline

I/ SR

Strong/CASP

Hou et al. (2018)

Medline

I/SR

Strong/CASP

Cui et al. (2016)

Pubmed

I/SR

Strong/CASP

Hou et al. (2016)

Hand search

I/ SR

Strong/CASP

Wu et al. (2017)

Hand search

I/SR

Strong/CASP
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Construction of Evidence-based Practice
Synthesis of Critically Appraised Literature
The goal of this evidence search and appraisal was to determine best practice for selfmanagement of T2DM. Studies and reviews regarding self-management of T2DM have used a
variety of interventions, including behavioral interventions, self-management behaviors via
different modes of technology, and provider-based interventions. Both intervention types were
categorized overall as disease self-efficacy and were evaluated many times throughout the
literature. With glycemic control being the major goal of treatment, the main outcome
measurements were average blood glucose and HbA1C levels. Within the search of the
literature, it was determined that mobile phone applications can improve self-management and
HbA1C levels of patients with T2DM (Minooee, 2020; Wu et al., 2017; Manuel, 2020; Alexandre
et al., 2021; Lizarondo, 2021; Pal et al., 2013; VA/DoD, 2017; Aminuddin et al., 2019; Wang et
al., 2019; Yoshida et al., 2018; Wu et al., 2019; Hou et al., 2018; Hou et al., 2016; Cui et al.,
2016). An extensive, systematic literature search was undertaken by the student project leader to
determine best practice.
Technology
There are many different interventions that fall under the term technology in T2DM
management. These technologies include computer-based interventions, telephone interventions
such as text messaging or calling, and mobile phone applications.
Computer-based. Computer interventions across the literature consisted of noninteractive learning modules, educational learning videos, touch screen interactive learning, and
e-mail (Pal et al., 2013; Yoshida et al., 2018). A systematic review evaluated the effectiveness of
computer-based educational interventions on HbA1C levels and found that this type of
intervention was not statistically significant in studies lasting more than six months (Pal et al.,
2013). This review found that the computer-based interventions showed a HbA1C reduction of
0.1% (95% CI -0.3-0.1) over the 6-month period, which was not statistically significant (Pal et al.,
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2013). This diminished effectiveness resulted in nonsignificant results and was seen again in
computer-based interventions lasting six months or longer (Lizarondo, 2021). Another evidence
summary suggested that at least 12 video messages over a 12-month period resulted in a
significant reduction in HbA1C levels at 0.6% reduction (Lizarondo, 2021). Based on these
results, the use of the computer-based interventions is inconclusive. Computer-based
interventions were also not associated with higher self-efficacy compared to other technology
interventions (Pal et al., 2013).
Telephone. Phone calls and text messaging have been utilized and studied as well for
management of T2DM. Across the literature, there was a variety of contact points and differing
durations of these interventions. Intervention time frames varied from four weeks to 12 months.
The effectiveness of telephone follow-up also varied across the literature. One evidence
summary suggested that telephone follow-up should be utilized in the management of patients
with T2DM (Manuel, 2020). Another summary reported that patients with T2DM should be
offered follow-up phone calls, but the intensity and frequency of the phone calls remains unclear
(Lizarondo, 2021). Mobile text messages may provide benefits in supporting self-management of
long-term illness, but this intervention’s effect on T2DM was not conclusive (Minooee, 2020).
Mobile-phone applications. The use of a diabetes-specific mobile phone application
was compared to other technology-based interventions throughout the literature. Worldwide
mobile phone usage is anticipated to exceed 5 billion by the end of the next decade (Hou et al.,
2016). Because of the increase and convenient use of mobile phones, the utilization of mobile
phone applications has significant potential to help with chronic disease management. Mobilephone applications were the most promising in reducing HbA1C levels and had the most
statistically significant results (Wu et al., 2017; Manuel, 2020; Lizarondo, 2021; Pal et al., 2013;
Aminuddin et al., 2019; Wang et al., 2019; Yoshida et al., 2018; Wu et al., 2019; Hou et al., 2018;
Hou et al., 2016; Cui et al., 2016). The literature revealed applications that were manual entry
and Bluetooth capable. Mobile phone applications across the literature included tracking self-
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care interventions, including blood glucose monitoring; exercise; diet; and blood pressure.
Application effectiveness was evaluated using HbA1c levels and glycemic control. The use of a
mobile phone application has been shown to decrease HbA1C levels and maintain better
glycemic control compared to computer-based and telephone interventions (Minooee, 2020;
Manuel, 2020; Lizarondo, 2021; Pal et al., 2013; Aminuddin et al., 2019; Yoshida et al., 2018;
Wu et al., 2019; Hou et al., 2018; Hou et al., 2016; Cui et al., 2016). Mobile phone applications
that had direct data transmission using wire or wireless connection were also associated with a
trend towards reduced HbA1c levels (Wu et al., 2017). Regarding technology, the use of a
mobile phone application appears to be the most consistent way to effectively reduce HbA1C
levels through T2DM self-management.
Provider-based Interventions.
Provider-based interventions included setting target HbA1C levels and providing
feedback on blood glucose readings (Minooee, 2020; VA DoD, 2017). One of the main factors for
successful disease management has been acknowledged to be interventions led by health
professionals (Alexandre et al., 2021). Regular medical reviews with practitioners were
associated with lower HbA1C levels and more effective self-management (Minooee, 2020;
Alexandre et al., 2021). One CPG concluded that improvements were seen in HbA1C levels
when patients had the ability to upload glucose monitor device data for review by their provider
(VA DoD, 2017). In another systematic review, studies with low provider feedback saw a 0.33%
HbA1c reduction (95% CI 0.07-0.59); in contrast, studies with high provider feedback saw a
1.12% decrease in HbA1c levels (95% CI 0.91-1.32) (Hou et al., 2018).
Outcomes
Average Blood Glucose
Throughout the literature, glycemic control was consistently measured through HbA1C
levels and is defined as a HbA1C level of less than 8.0 (ADA, 2018). In the review of the
literature, glucose levels were commonly equated or measured with HbA1C levels as this gives
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an average of glycemic control. HbA1C levels reflects the average glucose over the previous two
to three months (ADA, 2021). This provides a way to monitor and measure a patient’s average
blood glucose over the prior three months and allows the clinician to evaluate the patient’s
progress in regard to the body’s metabolic ability (ADA, n.d.). While HbA1C target levels can
vary by each person’s age and other medical conditions, generally speaking, the goal for most
adults with T2DM is a HbA1C less than 7% (ADA, n.d.). Similarly, average blood glucose levels
were chosen as primary outcomes in many pieces of literature chosen for evaluation and
utilization in this project. Throughout the literature, the use of a mobile phone application showed
a statistically significant reduction in HbA1C levels (Wu et al., 2017; Pal et al., 2013; Aminuddin
et al., 2019; Wang et al., 2019; Yoshida et al., 2018; Wu et al., 2019; Hou et al., 2018; Hou et al.,
2016; Cui et al., 2016).
The American Diabetes Association (ADA) discusses in their 2021 guidelines the term
time in range (TIR). This idea encompasses blood glucose readings that are within target, below
target, and above target (ADA, 2021). Each patient has their own target range and allows for
individualization of treatment and care plans. TIR is associated with many microvascular risk
factors, but the ADA recommends that this measure be used in future clinical trials and can be
used for assessment of glycemic control moving forward (2021). TIR accounts for time below
target and time above target and acknowledges that these can be useful parameters for
providers for evaluation of the treatment regimen (ADA, 2021).
Wu et al. (2017) performed a systematic review of RCTs to evaluate the effectiveness of
diabetes-specific mobile phone applications and their effects on disease management and effect
on average glucose levels. Within this systematic review, it was concluded that the use of a
mobile phone application was associated with a clinically significant HbA1C reduction of 0.48%
(95% CI 0.19%-.78%, I2=76%, P<0.001) compared to those who received standard of care alone
(Wu et al., 2017). Similarly, another systematic review found that the use of a diabetes-specific
application resulted in a statistically significant HbA1C reduction of -0.55% (95% CI -.60 to -0.40;
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P<0.001) (Aminuddin et al., 2019). Hou et al. (2018) performed a systematic review and metaanalysis regarding the use of diabetes mobile phone applications and their effects on HbA1C
levels. It was found that applications were associated with a mean HbA1C reduction of 0.57%
(95% CI 0.32-0.82; P<.01) (Hou et al., 2018). A RCT evaluated the effectiveness of a mobile
phone application and its effect on average blood glucose readings. It was concluded that
continuous care utilizing a mobile application significantly lowered the patients’ blood glucose
levels and reduced HbA1C levels six months after initiation of the intervention (Wang et al.,
2017).
Wu et al. (2017) evaluated the effectiveness of the mobile phone application comparing
different types of diabetes and found that the application was most effective in lowering HbA1C
levels for patients with T2DM (MD 0.67%, 95% CI 0.30%-1.03%, I2=47%, P=.11). This same
systematic review also concluded that applications with direct data transmission and a structured
display were associated with larger trends towards reduced HbA1C levels (Wu et al., 2017).
Self-Efficacy
Self-efficacy is defined as one’s confidence in one’s ability to successfully execute
behaviors required in producing desired outcomes (Aminuddin et al., 2019). Self-efficacy
activities for persons with T2DM include correct medication titration adherence, diet knowledge,
adequate exercise, and blood glucose control. Of note, the terms self-efficacy and selfmanagement were used equally and have the same meaning throughout the literature. A
patient’s knowledge about T2DM and motivation should be assessed and considered when
thinking about self-efficacy (Alexandre et al., 2021; Wang et al., 2019). A systematic review
suggested that if a patient has a positive relationship and support from family/friends and the
provider, their self-efficacy may be much higher than if those two factors are missing (Alexandre
et al., 2021).
In summary, the results of the literature review provided evidence indicating that
diabetes-specific mobile phone applications can be utilized to improve self-efficacy of patients
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with T2DM and HbA1c levels (Minooee, 2020; Wu et al., 2017; Manuel, 2020; Alexandre et al.,
2021; Lizarondo, 2021; Pal et al., 2013; VA/DoD, 2017; Aminuddin et al., 2019; Wang et al.,
2019; Yoshida et al., 2018; Wu et al., 2019; Hou et al., 2018; Hou et al., 2016; Cui et al., 2016).
Throughout the literature search, it was determined that mobile health applications and their use
for chronic disease management are increasing and have been shown to be an effective tool for
increasing self-efficacy or self-management.
Recommendation for Best Practice
Best practice recommendations include a diabetes-specific multimodal mobile phone
application that has the capability for providers to provide feedback to the user (Wu et al., 2017,
Alexandre et al., 2021; Minooee, 2020; Lizarondo, 2021; VA DoD, 2017; Hou et al., 2018). The
use of a diabetes-specific multimodal mobile phone application has been shown to effectively
decrease average blood glucose levels and in turn decrease HbA1C levels and complications of
T2DM (Minooee, 2020; Wu et al., 2017; Manuel, 2020; Alexandre et al., 2021; Lizarondo, 2021;
Pal et al., 2013; VA/DoD, 2017; Aminuddin et al., 2019; Wang et al., 2019; Yoshida et al., 2018;
Wu et al., 2019; Hou et al., 2018; Hou et al., 2016; Cui et al., 2016). Of note, in the ADA 2021
standards of care, TIR should also now be evaluated as a measure of glycemic control and will
be used more often moving forward.
The clinic where the project will be held has a pre-established agreement with Accu-Chek
Guide Me© and the Roche© application mySugr ©. This agreement allows the meter and the
mobile phone application to be interconnected via Bluetooth. This allows for patients to track
glucose readings, physical activity, diet, and medication adherence. This mobile phone
application has the capability of generating reports that are available for downloading by the
application user and can easily be sent to healthcare providers. The reports allow the provider to
evaluate estimated HbA1C levels, average blood glucose readings, and time in range. Based on
the reports, the application meets the standards of care of the ADA. Thus, the use of the AccuChek Guide Me© and the mySugr© mobile phone application may result in improved self-
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efficacy and disease management, which in turn may result in improved blood sugar monitoring
efforts, medication adherence, and involvement in physical activity. The literature shows that
diabetes-specific mobile phone applications can assist patients in achieving lower average blood
glucose readings and HbA1C reduction ranging from 0.48% to 0.57% (Pal et al., 2013;
Aminuddin et al., 2019; Yoshida et al., 2018; Wu et al., 2019; Hou et al., 2018; Hou et al., 2016;
Cui et al., 2016).
Computer-based interventions and phone or text messaging interventions have shown to
have some beneficial effects on HbA1C levels and self-efficacy. Across the literature, the results
from these interventions have been less consistent than those results of interventions involving
mobile phone applications. HbA1C levels were reduced by a range of by -0.2 to -0.57 (Pal et al.,
2013; Yoshida et al., 2018). The use of computer-based interventions were found to be more
variable and less consistent with the reduction of HbA1C levels compared to other interventions.
The literature also suggests that measuring baseline self-efficacy is beneficial before
starting any technological intervention (Minooee, 2020; Alexandre et al., 2021; Lizarondo, 2021;
Aminuddin et al., 2019; Wang et al., 2019). Performing baseline assessments may be beneficial,
so time is not wasted going over self-management education that is already known to the patient.
After mobile phone application education and implementation occurs, both individual self-care
behaviors and self-efficacy should be monitored (Alexandre et al., 2021).
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CHAPTER 3
IMPLEMENTATION OF PRACTICE CHANGE
The proposed project included the implementation of a diabetes-specific multimodal
mobile phone application and the evaluation of its effect on average blood glucose levels, time in
range, and self-efficacy. This project was created in conjunction with the project site nurse
practitioner to determine if the utilization would aid in T2DM management. The project was
implemented by the student project leader, a nurse practitioner that oversaw and assisted the
student project leader, and one clinical pharmacist. Participants were recruited through
retrospective chart review and recruited by staff at the project site. Participants were 18 years or
older, had a HbA1C greater than 8%, had a smart phone that was used to download the
application used for the project, had an Accu-Chek© Guide Me glucose meter for utilization in
combination with the application, and were English speaking. The Accu-Chek© Guide Me meter
could be connected via Bluetooth to the mobile phone application, allowing data to flow over into
the application without requiring any further action from the user. Exclusion criteria from this
project was patients under the age of 18, patients who did not have a smartphone, patients that
utilized continuous glucose monitors and/or insulin pumps, patients whose primary language is
something other than English, and pregnant women. Patients with drug or alcohol abuse,
dementia, or any other debilitating diseases that could have affected their ability to comply with
the project requirements were also excluded. The project compared pre- and post- average
blood glucose levels and TIR to evaluate the effect of the mobile phone application. Secondary
outcomes were the effect of the mobile application on estimated HbA1C levels and self-efficacy.
The estimated HbA1C levels were generated within the application using participants average
blood glucose levels throughout the duration of the project.
The mobile application that was utilized was mySugr©. The application was a multimodal
smart phone application that allows users to enter personal data including diet, exercise, glucose

22
levels and medication administration. The main management functions that were utilized in this
project were average glucose levels, exercise, and diet tracking. The exercise and diet tracking
features were classified as self-management behaviors. The application also automatically
generated estimated HbA1C levels, average blood glucose levels, and TIR. Once participants
were recruited and consent was obtained, there was an estimated 1-hour phone call with each
participant to collect demographic data (Appendix C), ensure proper education of the application
(Appendix K), ensure glucose meters were connected correctly, and a provided explanation of
the project’s goal was given (Appendix B). Within the consent, participants agreed to participate
and were informed that they could withdraw from the project at any time and if they chose to
withdraw, their health care was not to be impacted. Demographic information including age, date
of birth, gender, highest education level, employment status, ethnicity, days spent in the hospital
related to diabetes over the last year, number of times blood glucose is checked per day, how
well the participant felt they manage their diabetes, and how regularly HbA1C was checked was
collected prior to starting the project. Demographic information was obtained with the use of a
written form that was completed by the student project leader over the phone and by chart review
(Appendix C).
Participants were contacted biweekly throughout the duration of the project to encourage
compliance. During these contact points, participants were asked how the application was
working for them, what problems they were experiencing, or if any technology was proving to be
troublesome. If during these phone calls the participants were experiencing low or high blood
glucose levels, the provider was notified via chart notification, or the participant was instructed to
call the project site triage phone line. If needed, the participants were able to contact the student
project leader with any questions or complications with the application via secure messaging
through the healthcare system. The participants were also asked to take a self-efficacy inventory,
the DES-SF, to assess knowledge at implementation and completion of the project. The reliability
of the DES-SF was determined to be adequate (a = 0.84) (Anderson et al., 2003). This scale
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was an eight item Likert scale that evaluates self-efficacy. At the completion of the eight-week
period, participants post-intervention average glucose level data was compared to preintervention data. Participants were asked DES-SF questions post-intervention and asked to take
a survey regarding project satisfaction (Appendix D). The participant satisfaction survey was an
eight item Likert-type scale and had participants answer a series of questions requiring answers
ranging from strongly agree to strongly disagree. Data was then analyzed by the student project
leader and shared with the project site key stakeholders.
Participants and Setting
Stakeholders that took part in the practice change included a nurse practitioner provider
at the clinic, a clinical pharmacist, and the student project leader. The nurse practitioner has
worked in the diabetes specialty clinic for seven years, managing patients with similarities to the
project participant population. The clinical pharmacist has worked at the project site for more
than 20 years, managing patients with diabetes. Clinical pharmacists at the project site were able
to adjust and prescribe diabetes medications as needed without the prescribing authority of a
physician or advanced practice provider. The pharmacist’s role in the project was to help with
patient recruitment and continue the project for patients who were started on the application. Two
additional providers were invited to participate but declined related to other commitments of the
academic medical center. However, they expressed interest in receiving the findings of the
project and would consider implementation based on project findings.
The project site was in a moderate-size, metropolitan area located in southern Wisconsin.
The project site was part of a larger health care system that has many locations throughout the
United States. The clinic where the project took place was a smaller, specialty clinic that
manages various types of endocrine disorders. The nurse practitioner and clinical pharmacist
involved in the project worked specifically within the diabetes management area of the endocrine
clinic and only manage patients with T1DM and T2DM.
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Participants who took part in the project included persons with T2DM with HbA1C levels
greater than 8%, who had access to a mobile smart phone, were 18 years or older, and spoke
the English language.
Pre-Intervention Group Characteristics
The participants that were recruited included patients with T2DM with a HbA1C greater
than 8%. The age range of participants ranged from 36-74 years, with majority of the sample
being composed of men. This was to be expected with the patient population as all patients that
receive care at this clinic were active-duty servicemen or veterans. The average educational
level of participants was high school educated or higher. Majority of the participants were no
longer working.
Intervention
To prepare for the initiation of the project and resulting practice change, a variety of steps
were taken. First, the student project leader evaluated the literature to determine best practice for
management of T2DM. The student project leader then collaborated with the nurse practitioner
who helped facilitate the practice change. The project location had Accu-Chek Guide Me©
glucose meters; this meter could be connected via Bluetooth to the application mySugr©.
mySugr© was a multimodal, diabetes-specific smart phone application that was used for the
project. This application allowed users to connect their glucose meter via Bluetooth to track their
blood glucose levels. Users of the application could also track diet choices, exercise, and any
necessary medication administration. The application also had the ability to generate PDF
reports of blood glucose readings that were uploaded into the MyHealtheVet electronic chart of
any participants for providers to review.
Participants were recruited via retrospective chart review and through recommendations
of the clinic staff at the project site. If a participant was identified as eligible to participate in the
project, the student project leader contacted them through MyHealtheVet secure messaging,
through communication with their provider, or via phone call. Potential participants that did not
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have MyHealtheVet activated were contacted by phone by the student project leader about how
to connect with the MyHealtheVet coordinator at the project site (Appendix G). Each participant
that met the inclusion criteria and expressed interest in the proposed project was given a 1-hour
introductory meeting to explain the goals of the project: lowering average blood glucose
readings, increasing TIR, and increased self-efficacy. In the introductory meeting, the student
project leader collected demographic information (Appendix C), assisted the participant in
downloading the application, conducted an educational session to explain use of the application
and how to upload information into MyHealtheVet (Appendix G), and had the participant fill out
the pre- DES-SF.
The intervention itself included the use of the diabetes-specific, smart phone application.
Participants were asked to track their blood glucose levels at least once per day with their AccuChek Guide Me© glucose meter for eight weeks; this information automatically flowed into the
smart phone application. Every two weeks, participants uploaded their PDF report of blood
glucose levels to the MyHealtheVet electronic medical record for review by the student project
leader, nurse practitioner, and clinical pharmacist. Participants were contacted via phone by the
student project leader on a biweekly basis to address any problems or concerns with the use of
the application. The student project leader evaluated average blood glucose readings and TIR
with each upload of the PDF to monitor compliance.
Comparison
Participants that were selected for this project were English speaking and reading, 18
years or older, clinically diagnosed with T2DM, had a HbA1C of 8% or higher, and owned a
smartphone. For this project and the site that was selected for the project, majority of the
participants were middle aged to elderly males with uncontrolled T2DM. HbA1C levels of
selected participants ranged from 8%-12% before the implemented intervention.
Throughout the literature, best practice was identified as the use of a multimodal,
diabetes-specific mobile phone application (Minooee, 2020; Wu et al., 2017; Manuel, 2020;

26
Alexandre et al., 2021; Lizarondo, 2021; Pal et al., 2013; VA/DoD, 2017; Aminuddin et al., 2019;
Wang et al., 2019; Yoshida et al., 2018; Wu et al., 2019; Hou et al., 2018; Hou et al., 2016; Cui et
al., 2016). The use of a mobile phone application has been shown to decrease HbA1C levels
and maintain better glycemic control (Minooee, 2020; Manuel, 2020; Lizarondo, 2021; Pal et al.,
2013; Aminuddin et al., 2019; Yoshida et al., 2018; Wu et al., 2019; Hou et al., 2018; Hou et al.,
2016; Cui et al., 2016).
Outcomes
The primary outcome of the project was average blood glucose levels. The goal of the
project was to utilize the diabetes-specific mobile phone application to overall lower average
blood glucose levels and increase TIR. The participants’ pre-intervention HbA1C level and
average blood glucose level were retrieved via retrospective chart review. The post-intervention
average blood glucose levels were evaluated and collected through chart review of the uploaded
PDFs from the mySugr© application on a biweekly basis. Secondary outcomes evaluated were
estimated HbA1C levels generated by the application and self-efficacy. Self-efficacy was
measured by using the DES-SF. This was an eight-item form and was created as a shorter
version of the Diabetes Empowerment Scale (Anderson et al., 2003). With the eight items, each
item required an answer ranging from strongly disagree to strongly agree. The goal of the form
was to measure diabetes-related psychosocial self-efficacy (Anderson et al., 2003). The
reliability of the DES-SF was determined to be (a = 0.84) (Anderson et al., 2003). All data that
was collected from each participant was managed by the student project leader using a
deidentification coding system.
At the completion of the project, the student project leader evaluated and analyzed the
data collected. For analysis, a paired sample t-test was used to evaluate the effectiveness of the
intervention. A Wilcoxon signed-ranked test was used to evaluate the effectiveness of the
interventions on self-care perceptions and self-efficacy.
Time

27
This project started on September 1, 2021 and had open enrollment for participants
which lasted from September 1, 2021 to October 31, 2021. With the utilization of open
enrollment, the student project leader anticipated an adequate number of participants and
ensured adequate data was collected during the project implementation. Data collection was
completed by December 31, 2021. Refer to Appendix J for a full timeline and visual of the
implemented intervention.
Protection of Human Subjects
Participants and their data were protected throughout the duration of the project. An
online ethics course was completed by the student project leader on April 5, 2021 through the
Collaborative Institutional Training Initiative (CITI). The completed training was entitled Social
Behavioral Educational Researchers; the completion certificate for reference is located in
Appendix F. IRB review was determined to be exempt from Valparaiso University and permission
to complete the project was obtained from the Chief Nursing Officer who regulated EBP at the
project site. Written consent for participation in the project was obtained after reviewing the goals
of the project, potential risks, benefits and harms, and the right to discontinue the project at any
time. Before presenting any of the data that was collected during the project, the project was
reviewed by the Nurse Executive Committee at the project site as this was part of their
requirement. All data that was collected during the project was kept secured via lockbox and
password protected computer. To ensure confidentiality for participants, each participant was
identified by using a code number. At the completion of the project and data analysis, all data
that was outside the participants’ chart was immediately destroyed.
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CHAPTER 4
FINDINGS
This EBP project was created to determine the effect of a multimodal smart phone
application and its effect on average blood glucose levels for adults with T2DM over an 8-week
period. The project will also evaluate the effective of the application for TIR and self-efficacy of
their disease through the DES-SF. Following the literature search, it was determined that this
intervention was most effective for patients with a HbA1C level of 8% or greater. Average blood
glucose levels were compared from pre-intervention and post-intervention through the use of the
mySugr© application. Secondary outcomes included TIR, DES-SF scores, and estimated HbA1C
levels. Statistical analysis was performed on project outcomes to determine significance of the
obtained results. Patient satisfaction scores were also collected at the end of project
implementation to evaluate ease of use of the application and project process. Participant
responses were recorded at the final phone meeting.
Participants
A total of 16 participants were initially recruited to participate in the project; of these, five
participants (31%) were lost to attrition prior to starting the intervention. The five participants who
were lost to attrition had similar age, sex, education level, and employment status as compared
to the participants who completed the project. The majority of the participants in this project were
Caucasian males (81.8%) with an employment status of retired (72.7%). This was similar to the
preintervention participants as well. Further demographic data for participants who completed the
project can be found in Table 4.1.
Providers involved in the project were one nurse practitioner working in the diabetes
specialty clinic who assisted with the development of the DNP project and one clinical
pharmacist who worked specifically in the diabetes clinic as well. An additional clinic nurse was
involved via providing coordination of care for participants enrolled in the project. There were two
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attending providers who decided not to participate in the project because of other commitments
to the academic medical center. They were required to train and oversee resident and fellow
physicians and felt the project would be too much of a responsibility on top of their other
requirements. They expressed their sympathy for not participating but were interested in
evaluating the results of the project.

30
Table 4.1
Participant Demographic Data
Demographic

n (%)

Age
Mean/ SD
Range
Gender
Male
Female
Race
African American
American Indian
Asian
Caucasian
Hispanic
Other
Employment
Part time
Full time
Retired
Unemployed
Education
Primary school
High School
University
Diabetes Management
Weak
Moderate
Strong

66/8.28
46-76
9 (81.8)
2 (18.2)
0 (0)
0 (0)
0 (0)
11 (100)
0 (0)
0 (0)
1 (9.1)
2 (18.2)
8 (72.7)
0 (0)
0 (0)
5 (45.5)
6 (54.5)
2 (18.2)
6 (54.5)
3 (27.3)
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Changes in Outcomes
The primary outcome of this project was average blood glucose levels after an 8-week
period. Average blood glucose levels were measured pre-intervention and compared to postintervention results. Secondary outcomes for the project were TIR, estimated HbA1c levels, and
DES-SF scores. Primary and secondary outcomes were measured and evaluated by statistical
analysis. In addition to these outcomes, patient satisfaction scores were collected to evaluate
patient perceptions of the project.
Statistical Testing and Significance
For data entry and statistical analysis, the 25th version of SPSS was utilized. Pairedsample t-tests were used to evaluate average blood glucose levels, TIR, estimated HbA1C
levels, and patient satisfaction scores. A Wilcoxon Signed Ranks test was performed to evaluate
DES-SF scores from before and after the 8-weeks of the intervention. Statistical significance for
all the analyses was determined as p <.05.
Findings
The primary outcome of this project was average blood glucose levels. Pre-and-postintervention data were evaluated using a paired sample t-test and were found to be statistically
significant. Secondary outcomes of this project included TIR, estimated HbA1C levels, and DESSF scores. The secondary outcomes were evaluated used a paired sample t-test and were found
to be statistically significant. Further analysis was performed for independent variables and their
effect on average blood glucose levels.
Primary Outcome
Average Blood Glucose. A paired samples t-test was utilized to evaluate the preand-post-intervention data for average blood glucose over the 8-week period. The mean preintervention average blood glucose was 192.7 mg/dL (SD = 41.01). After the 8-weeks of the
intervention, the mean average blood glucose was 178.54 mg/dL (SD = 37.28). With this data a
paired-samples t-test was performed and a significant difference was found in the average blood
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glucose of the participants from the beginning of the program to the end of program (p = .008).
The average decrease in blood glucose was found to be 14.18 mg/dL (SD = 14.09). Figure 4.1
demonstrates the difference between pre-and-post average blood glucose levels.
Furthermore, an analysis was performed to evaluate the effects of education, gender,
age, employment, days in the hospital, perception of diabetes self-management, and patient
satisfaction on average blood glucose levels. A linear regression model was performed, and it
was determined that the variables of different education levels (t = .001), gender (t = .190), age (t
= .-.123), employment (t = .296), number of days of hospitalization (t = -.234), and selfmanagement (t = .648) did not influence average levels of blood glucose.
After this, a further analysis was performed to evaluate education, age, education and
age, and gender to determine if these individual demographic characteristics had a significant
impact on average blood glucose. A Kruskal-Wallis test was used to evaluate education and its
effect on average glucose levels and was found to be not significant (p = .173). An independent
t-test was used to evaluate age and its effect on average blood glucose and was also not
significant (p = .123). A linear regression model was performed to evaluate the combination of
education and age on average glucose levels. The independent variable of age was not
significant (p = 0.076); the independent variable of education was not significant either (p =
0.130). Thus, participants’ age and education level did not have an effect on average blood
glucose levels for the participants in this project. Lastly, an independent t-test was calculated to
evaluate average blood glucose levels for males and females. This calculation was not
significant (p = .904), indicating there is not a difference between male and female participants in
this project.
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Figure 4.1
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Secondary Outcomes
Time In Range. TIR was evaluated by running a paired samples t-test. The paired
samples t-test was statistically significant (t (10) = -3.58, p = .005). The mean for pre-TIR (M=
55.63, SD = 20.56) was significantly different from the post-TIR (M= 68.63, SD = 20.60). Since
the test statistic is negative, another analysis was performed and found the one-sided p-value to
be p = .0025). Figure 4.2 demonstrates differences between pre-and-post TIR.
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Figure 4.2
Pre-Post Intervention Time-In-Range Percentage
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Estimated HbA1C. A paired samples t-test was performed to evaluate pre-and-post
estimated HbA1c levels. The participants’ mean pre-HbA1C level (M = 8.74, SD = 1.22) was
higher than the post-HbA1C levels (M = 7.89, SD= 1.28) for the participants. After running the
paired samples t-test, the difference in the data was found to be statistically significant (t (10) =
5.068, p = 0.00048). Figure 4.3 demonstrates differences between pre-and-post estimated
HbA1C levels.
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Figure 4.3
Pre-Post Intervention Estimated HbA1C
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DES-SF. A Wilcoxon Signed Ranks Test was performed to analyze DES-SF
questionnaire scores from the beginning to the end of the project. The DES-SF post-total was
significantly different from the DES-SF pre-total (p = 0.007). When examining the ranks, it
appeared that nine out of 11 times, the DES-SF post-total was higher than the DES-SF pre-total.
With this conclusion, the participants had higher scores or improved on the questionnaire from
the beginning of the project to the end.
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CHAPTER 5
DISCUSSION
The purpose of this EBP project was to lower average blood glucose levels through the
utilization of a multimodal smartphone application. The project was created to answer the
following PICOT question: In adults with type 2 diabetes mellitus with a HbA1C greater than 8%
(P) in a diabetes specialty clinic, what is the effect of a multimodal smartphone application (I)
compared to prior nonuse of the application (C) on average blood glucose readings (O) over an
8-week period (T)? This chapter will discuss and interpret statistical testing of the project,
strengths and limitations, and implications for future practice.
Explanation of Findings
Overall, the project supported the use of a multimodal smartphone application for the selfmanagement of adults with T2DM. Results were consistent with the literature that was used to
create this project, in which this intervention was shown to be the most effective. Participant
findings, project findings, statistical and clinical significance and analysis will be discussed further
in this section. Of note, there has not been any new research with differing results or
interventions related to the use of a multimodal smartphone application since the above literature
search was performed.
Demographic Findings
Demographic data for participants were collected and analyzed to evaluate if any
significant differences existed between gender, age, and education level. Race was excluded
from the analysis because all of the participants were Caucasian. After analysis of the 11
participants, there was no difference for gender (p = .904), age (p = .123), or education level (p =
.173). Age of the participants had no impact on the results of the project. While there was no
significant difference in gender and its effect on average blood glucose levels, there was a large
discrepancy for males and females in the participant sample. Within the 11 total participants,
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there were nine (n = 9) males and only two (n = 2) females. There was no statistically significant
difference between gender, but if the sample size was larger and consisted of more females, the
results of gender impact could differ. In regard to education level, all of the participants had at
least a high school level education. Because of this, implementation of the reading material and
troubleshooting during the project was much simpler. If the education levels of the participants
were to be lower, reading materials for the project would need to be adjusted.
Average Blood Glucose
Based on the paired-samples t-test that was calculated for the intervention, a statistically
significant difference was found for average blood glucose levels after an 8-week period.
Participants were asked to track their blood glucose at least twice daily over the 8-week
intervention period and upload their results every two weeks to maintain compliance. Average
blood glucose levels were compared from the initial upload and at the end of the project. A twosided analysis was completed and there was a significant difference in the average blood
glucose levels of the participants from the beginning of the program to the end of the program (p
= .008). The mean from beginning average blood glucose levels to end average glucose levels
was M = 14.18 (SD = 14.09). It was determined that there was sufficient evidence to support that
the average blood glucose levels of the participants from the beginning of the project was larger
than the average blood glucose levels of the participants from the end of the project.
TIR
Time in range (TIR) is discussed by the ADA as the idea of blood glucose readings being
within target, below target, or above target (ADA, 2021). Each patient has their own target for
blood glucose that allows for individualization with TIR. TIR has been associated with many
microvascular risk factors, and the ADA recommended that this measure be used in future
clinical trials and can be used for assessment of glycemic control moving forward (ADA, 2021).
Because of this, the NP that assisted the student project leader with the project development
recommended using this measure in the project. A paired samples t-test was used to evaluate
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the TIR in this project and produced a statistically significant result from the start of the project to
the end of the project (p = .0025). This could be assumed because of the statistically significant
results with decreased average blood glucose levels. If participants overall had lower blood
glucose levels, the TIR would increase. The inverse would be true as well. If participants did not
have lower blood glucose levels, their TIR would not improve or could have possibly become
worse.
Estimated HbA1C
Throughout the literature, glycemic control was consistently measured through HbA1C
and was defined as a HbA1C less than 8.0 (ADA, 2018). A HbA1C level provides insight into a
person’s average blood glucose over a prior period of three months and monitors progress in
regard to the body’s metabolic ability (ADA, n.d.). HbA1C was initially going to be used to
evaluate the participants progress in the project over a 12-week period. Because of the
restrictions from the project site, this idea had to be discarded. Instead, the application that was
chosen for the project had the ability to generate an estimated HbA1C level based on the blood
glucose PDF reports over a two-week period. The participants pre-estimated HbA1C was then
compared to the post-estimated HbA1C and evaluated using a paired samples t-test. It was
determined that pre-to-post estimated HbA1C demonstrated a statistically significant difference
for the participants (p = .000486). It would be more accurate to obtain the blood test for HbA1C
instead of using an estimated number but because of project site restrictions, estimated HbA1C
levels were used in its place.
DES-SF
A Wilcoxon Signed Ranks Test was used to evaluate pre-DES-SF and post-DES-SF
scores. After running this test, a significant difference was found in the scores (p = .007). When
examining the ranks, nine out of eleven times the DES-SF post-total had a higher score than the
DES-SF pre-total. With this conclusion, the participants had higher scores, or they improved on
the DES-SF questionnaire from the beginning of the intervention to the end of the intervention.
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The average pre-DES-SF total was 30.55 and the average post-DES-SF total was 33. Two
participants scored the same from pre to post scoring. A Cronbach’s alpha was performed for the
eight domains of the DES-SF questionnaire to evaluate internal consistency of the questionnaire.
Ideally, high levels of internal consistency would be demonstrated by an alpha of greater than 0.7
and results closer to 1.0 would demonstrate an even higher level of reliability. The pre-DES-SF
alpha results were .809 compared to post-DES-SF alpha of .684. These results suggest that the
pre-DES-SF scores were more reliable than post-DES-SF scores. These results can be more
beneficial with a larger sample size.
Patient Satisfaction
Patient satisfaction scores were measured at the end of the project used an 8-item Likert
scale tool. An independent samples t-test was used to evaluate if there was a difference in
average blood glucose levels between not-satisfied participants, who rated 1-3 on the
satisfaction survey questions, and satisfied participants, who rated 4-5 on the satisfaction survey
(Appendix D). When comparing the two groups, there was not a significant difference in the
average amount of glucose no matter if they were satisfied with the project or not. An analysis
was also performed for each question on the satisfaction survey to assess how frequently each
answer was chosen. For many of the questions, participants answered with a six, which signified
that they strongly agreed with the question. Many of the participants also responded with a 4,
which signified that they agreed with the question. Overall, the participants were satisfied with
the project except for when it came to evaluating question six of the survey (Figure 5.1).
Question six of the survey evaluated how participants felt that the application helped them track
their diet and exercise. Almost half of the participants responded with one or two, which signified
that they either strongly disagreed or disagreed with the statement. This may be related to lack of
knowledge of how to enter this into the application. Participants were given instruction on this
during the initial phone meeting, but when asked why this data was not entered or they felt that
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the part of the application was not helpful, the most common response was that they forgot to do
it, or it was too complex.
Strengths and Limitations of the DNP Project
Strengths
A thorough and comprehensive search of the literature was performed with the
assistance of the Valparaiso University College of Nursing and Health Professions librarian.
Finding and analyzing the highest quality evidence was a major strength of this project and
played a large role in its development. Throughout the search of the literature, the use of a
mobile phone application was shown to be best practice and had the strongest evidence for
successful outcomes, which was the reason for implementing mySugr© in this project.
In addition to the comprehensive search of the literature, there were many identified
strengths throughout the duration of the project. One of the main strengths of this project was
interprofessional communication. During the development phase of this project, there were many
identified challenges which pushed the student project leader to communicate efficiently and
effectively to ensure the project would be implemented to its fullest potential. Another strength
was the technology that was chosen for the project; this included the mySugr© application, the
Accu-Chek Guide Me© glucose meter, and the MyHealtheVet secure messaging system.
Working with technology that the clinic already had supplied for patients facilitated and provided
a smooth implementation phase of the project. With the ability of the glucose meters to connect
via Bluetooth to the application, it was much easier for participants to remain compliant with the
project and send their data for review. The ability for participants to be able to join the project at
no cost to them was also a significant benefit.
Lastly, the support from the NP that worked closely with the student project leader led to
great success with the participants. The NP was willing to be very attentive to MyHealtheVet
messages that were being sent in by participants. This included reviewing their data and
providing feedback and medication adjustments in a timely manner. The student project leader
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was able to smoothly implement the project and discuss results with the NP from each
participant’s data. The clinic staff was also very supportive of the project. RNs would direct
participant data to the student project leader’s inbox on MyHealtheVet to provide notification of
their data submission. The student project leader was then able to review and discuss results
with the NP.
Limitations
There were many identified barriers in the planning and implementation phase of this
project. During the planning phase of the project, the student project leader encountered many
problems with the facility itself. The original project idea was to implement the same application
and to have the main outcome be HbA1C levels after 12 weeks of implementation. Each contact
with participants was planned to be in person or through video chat through the electronic
medical record used by the facility. The EBP coordinator of the facility deemed that it was
unethical to have participants have another HbA1C drawn just for the purpose of this project;
therefore, this idea had to be discarded. The in-person visits had to be discarded as well, related
to the COVID-19 pandemic and restrictions regarding extra persons in the clinic. Video calls
were not able to be conducted related to specific security clearance being needed for the clinical
facility. Phone visits were used in place of in-person and video visits. Phone contact visits were
also a challenge related to calls dropping or phone calls not being answered. To manage all of
these challenges, the student project leader engaged in multiple meetings with the EBP
coordinator of the facility, an EBP nurse employed by the healthcare system, the nurse
practitioner involved in the project, and the student project leader’s project advisor.
During the implementation phase of the project, more challenges arose. One of the main
challenges experienced during implementation was with the technology used. The application
mySugr© was used along with the electronic medical record employed by the facility. Because
contact time with participants had to be conducted over the phone, explaining to participants how
to upload their PDF forms from the application was extremely difficult. The average age of
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participants was 66 years of age, and many were unfamiliar with how to work a smart phone
application. The PDF forms were then uploaded through the secure messaging system used by
the facility. There were multiple steps needed for downloading the PDF from the application,
saving it to the participants computer, and then uploading it into the secure messaging system.
This posed a significant challenge to many participants due to the lack of knowledge for using a
laptop or desktop computer. Along with technology, many participants did not have high-speed
internet or strong Wi-Fi connections. This was a challenge because much time was spent on the
phone waiting for the application to generate the PDF or for the computer to get to the correct
page for uploading the documents.
Lastly, time allowed for the project was a large challenge. Implementation of the project
had a very limited time window. The project was implemented from September 2021 through
December of 2021. This only allowed two months for recruitment of participants and two months
for implementation. Since data were collected for 8-weeks, only two months was allowed for
recruitment of participants. If the student project leader was allowed more time for recruitment of
participants, the number of participants might have been higher. A full timeline of the project can
be found in Appendix J.
Sustainability
The goal at the end of implementation was for the project site to continue the student
project leader’s project at its completion. After completion, the plan was for the patient education
resource center (PERC) at the project site to continue education and onboarding of patients with
the application use. The student project leader was going to supply the PERC with resources
that were supplied to project participants during project implementation. A short educational
session was provided to PERC employees about how the application works and how to educate
patients on its use. The PERC already assists patients with the use of MyHealtheVet, so no
further action will be needed in that aspect of continuation with this piece of the project. The
educational flyers created by the student project leader that were used in the project for
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education were also given to the PERC for use and continuation of the application. Ideally, this
was seen as the best way to maintain sustainability after discussion with the NP.
After discussion with the PERC, it was determined that they were not able to assist
patients with this, as they are already extremely busy with other aspects of care. Instead, the
student project leader worked with the clinic CDCES to establish how the project would still
continue. The educational packets that were created are going to be either sent to the patient’s
MyHealtheVet account or mailed to their house. Patients will be able to contact the PERC for
help with access to MyHealtheVet and getting this set up. For getting the application set up, they
will be instructed to follow the directions in the packet and contact the clinic with any questions;
the clinic CDCES will follow up with them.
The nurse practitioner who assisted the student project leader with implementation of the
project also suggested continuation through the CDCES. The CDCES was involved in the
recruitment process of the project and is very familiar with the process needed for continuation of
the application use. The CDCES will be responsible for referring patients to the PERC for further
educational needed regarding the application use and MyHealtheVet use.
Relevance for EBP Model
The JHNEBP model was used to plan, implement, and evaluate the project. The JHNEBP
model was created as a way to transition EBP into practice (Melnyk & Fineout-Overholt, 2019).
In this model, there are a total of 18 steps that are broken down into the three main categories
known as the PET process: practice question, evidence, and translation. Overall, this model was
a good fit for this project. In the practice question phase, all steps were used except for the
scheduling of team meetings step. This step was just simply not feasible within this clinic
because of the COVID-19 pandemic and the differing duties of the NP and the nurses in the
clinic. The clinical pharmacist also was not easily able to attend meetings. The student project
leader connected with each member of the team individually and communicated what other
members of the group were thinking or what concerns were present.
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In the evidence step, all five steps were used. The student project leader conducted
internal and external searches for evidence, appraised the level and quality of each piece of
evidence, summarized the individual evidence, synthesized overall strength and quality of
evidence, and developed recommendations for change at the project site based on the evidence
found (Melnyk & Fineout-Overholt, 2019). Lastly, all eight translation steps were used:
determining fit, feasibility and appropriateness of recommendations for translation path; creating
an action plan; securing support and resources to implement action plan; implementing action
plan; evaluating outcomes; reporting outcomes to stakeholders; identifying next steps; and
disseminating findings (Melnyk & Fineout-Overholt, 2019).
Based on the student project leader’s experience with the JHNEBP model, a
recommendation would be made to divide the translation step into two phases or two separate
steps. This phase comprised much of the time spent with the project. The eight steps in this
phase could be divided into planning which would include: determining fit, feasibility and
appropriateness of recommendations for translation path, creating an action plan, and securing
support and resources to implement action plan. The second part of this phase would include:
implementing action plan, evaluating outcomes, reporting outcomes to stakeholders, identifying
next steps, and disseminating findings. The student project leader felt overwhelmed with all of
the duties listed in this phase. To avoid this, the PET process could be divided into four phases
instead of three or divide the translation phase into two separate parts so that this step is more
manageable.
Recommendations for the Future
The findings from this EBP project provided valuable information for the self-management
of T2DM that was consistent with the previous literature search. Further research and education
recommendations will be discussed in detail. These recommendations can be considered and
used to guide or improve future EBP project and continue to improve the self-management of
T2DM.

45
Research
Further research is needed to explore the effect of mobile phone applications for the
management of T2DM. Within the literature search, there was a lot of evidence for the use of
different technological devices for the management of T1DM, but solid evidence for management
of T2DM was scarce. Many of the studies evaluated many different types of technology including
computer-based interventions, telephone call based, or mobile-phone applications (Minooee,
2020; Wu et al., 2017; Manuel, 2020; Alexandre et al., 2021; Lizarondo, 2021; Pal et al., 2013;
VA/DoD, 2017; Aminuddin et al., 2019; Wang et al., 2019; Yoshida et al., 2018; Wu et al., 2019;
Hou et al., 2018; Hou et al., 2016; Cui et al., 2016). Because mobile phone usage is expected to
exceed 5 billion by the end of the next decade, more research regarding the use of specific
mobile phone applications is needed to further evaluate its effect (Hou et al., 2016). Going
forward, it would be ideal for researchers to start utilizing TIR when evaluating patient outcomes
since this is now the standard of the ADA. Additionally, to be eligible for this project, participants
had to be at least 18 years of age. The mean age of participants in this project was 66.0 (SD =
8.2). Further research should be focused on younger populations with T2DM in the hopes that
people with more experience with technology could utilize the mobile phone applications to their
fullest ability.
Education
Education is an extremely important part of taking care of patients as an advanced
practice nurse. Participants in this project were started with an introductory educational session
where they were instructed how to properly connect their glucose meters to the mySugr©
smartphone application, how to use the application, and how to upload their PDF forms to the
MyHealtheVet secure messaging system. Participants were also instructed and educated on how
they would be contacted and what the options were for the NP to contact them after submitting
their PDF documents for review. Participants were provided education but along with them, key
stakeholders in the project were educated on the project as well. Clinic staff were given
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information regarding the application and how they would be able to help participants if questions
arose.
Education should be provided to advance practice nurses that this is the best way to
encourage patients to take control of their T2DM. Research should be presented in a way that
demonstrates that when patients are provided with feedback on their data, their average blood
glucoses are more likely to improve. Moving forward, education should be provided to physicians
and advanced practice providers who could be managing patients with T2DM. Education should
also include diabetes educators as this could be something that nurses of this role could take on
to assist patients with implementation of a mobile phone application.
Conclusion
Diabetes was the seventh leading cause of death in the United States in 2017 and affects
34.2 million Americans, with an additional 1.5 million new diagnoses every year (ADA, 2018).
With the aging population and obesity rising in the United States, this number of affected
Americans will only continue to grow. Due to the many complications and complexities that come
along with uncontrolled T2DM, effective disease self-management is essential.
This project answered the PICOT question: “In adults with type 2 diabetes mellitus with a
HbA1C greater than 8% in a diabetes specialty clinic, what is the effect of a multimodal
smartphone application compared to prior nonuse of the application on average blood glucose
readings over an 8-week period?” Results from this project support the use of a multimodal
smartphone application for the management of T2DM in adults. The goal of the project was to
evaluate if the smartphone application would be beneficial in adults with T2DM and overall lower
average blood glucose levels. Secondary outcomes included TIR, estimated HbA1C levels, and
DES-SF scores. Statistically significant results were found in average blood glucose levels, TIR,
estimated HbA1c levels, and DES-SF scores. The results of this project are consistent with the
prior evidence found throughout the literature search in determining a mobile phone application
is the most effective way for patients with T2DM to lower their average blood glucose effectively
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(Minooee, 2020; Wu et al., 2017; Manuel, 2020; Alexandre et al., 2021; Lizarondo, 2021; Pal et
al., 2013; VA/DoD, 2017; Aminuddin et al., 2019; Wang et al., 2019; Yoshida et al., 2018; Wu et
al., 2019; Hou et al., 2018; Hou et al., 2016; Cui et al., 2016).
Sustainability of this project was discussed with the clinic staff to allow for continuation of
the use of the application for management of adults with T2DM. Because the clinic provides
glucose meters and a free Pro-version of the application, the project is much easier to sustain.
Overall, the use of the mobile phone application mySugr© represented a way for participants to
lower average blood glucose levels in a cost-effective manner and increase their interaction with
their healthcare provider.
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APPENDIX A
Evidence-Based Practice Project Flyer

Empower You: An Adult Type 2 Diabetes Mellitus
Management Program
Provider Information:
Purpose: This is an evidence-based practice pilot project aimed at reducing glycated
hemoglobin, while also trying to encourage self-care perceptions and behaviors, including
medication adherence, blood glucose monitoring, and physical activity through the use of the
diabetes-specific mobile smart phone application mySugr©.
Inclusion Criteria: Participants must be 18 years or older, have type 2 diabetes, have the most
recent HbA1c of greater than 8%, and have access to a mobile smart phone. Pregnant women,
patients on insulin pumps or continuous glucose monitors are not able to participate in this
project.
Evidence-Based Project Information:
• No cost 8-week project to encourage self-management behaviors for persons with T2DM
will be managed by the DNP student project leader
• Free, diabetes-specific mobile phone application, mySugr© to be downloaded to
participants smart phone (Android or Apple compatible)
• 1-hour in-person or video introductory visit provided with the student project leader to
discuss mySugr©, technology involved in the project, and goals of the project.
Participation is voluntary, participants can drop out at any time with no effect on care
provided at the clinic, and written consent will be obtained.
• The project will include:
o Evaluation of most recent HbA1C level
o Pre/post project average blood glucose readings and time in range
o Pre/post project satisfaction survey
o Weekly/ biweekly phone contact with student project leader to assess project
compliance, any technologic issues, or questions
o Participants with significant hypo/hyperglycemia episodes will be referred to their
healthcare provider
• Each participant will be encouraged to try and use the application for at least 8-weeks,
upload their data into MyHealtheVet, and send to the student project leader. They may
choose to stop the program at any time for any reason.
Questions or Possible Participants?
• Contact student project leader- Kelsey Jahn
o 608-852-3749 or Kelsey.jahn@valpo.edu

55
APPENDIX B
Patient Information Flyer

Empower You: An Adult Type 2 Diabetes
Mellitus Management Program

Type 2 diabetes mellitus is one of the top seven most common chronic disease, and the number of
people with diabetes is getting higher every year.
Managing diabetes is hard and can cause many problems like heart attack, stroke, bad vision, pain
in the feet, and bad kidneys. A HbA1c level above 8% makes the risk higher.
The use of a mobile phone application has been shown to lower blood sugars, increase exercise,
help with medications, and lower HbA1c.
Empower You is a program at William S. Middleton Veterans Affairs Hospital and was made
because of research that shows mobile applications lower HbA1c taking medication, blood sugar,
and doing exercise.
When you join the 8-week program, you will get hands-on and written details for downloading
the free app, using the app, and uploading your information for your health care provider to
review at a time that is easy for you.
The program will use the app mySugr©. This can be used with an Android or iPhone. There is no
cost to join.
Please ask you provider if they think you could be in the program. You must be 18 years or older,
have type 2 diabetes, have a HbA1c more than 8%, and have a smart phone. Pregnant women are
not able to be in this program.
Student Project Leader Contact Information
Kelsey Jahn
RN, BSN. DNP-FNP Student
Program Leader
Contact Information
608-852-3749
Kelsey.jahn@va.gov

Project Affiliates
Jessica Phelan FNP-BC
Diabetes Specialty Clinic
William S. Middleton VA Hospital
Clinical Site Preceptor
Rose Flinchum
Valparaiso University Project
Advisor
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APPENDIX C
Demographic Form
Empower You: An Adult Type 2 Diabetes Mellitus Management Program
Kelsey Jahn RN, BSN, DNP Student, Student Project Leader
Valparaiso University
Demographic Data Collection Form
Instructions: Fill out the blanks OR check the box that applies to you. Please complete the form
and return to the student project leader.
Code: ____________ (Project leader use only)
Age (in years): ____________
Date of birth: ______________
Gender:

▢Male ▢Female
▢Non-Binary
▢Prefer not to choose
▢Prefer to self-describe: ____________

Highest Educational Level:
▢Primary school (K-8th grade)
▢High school (9-12th grade)
▢University (Post 12th grade)
Ethnicity:
▢African American
▢American Indian
▢Asian
▢Caucasian
▢Hispanic
▢Other
Number of times per day
you check blood sugar
▢0
▢1
▢2
▢3 or more

Employment:
▢Employed Part Time
▢Employed Full Time
▢Unemployed
Days in hospital from Diabetes in the past year:
▢0-1 days
▢2-3 days
▢4-5 days
▢6 or more days

How well you feel you manage T2DM:
▢Weak management
▢Moderate management
▢Strong management

Do you get HbA1c checked regularly?
▢Yes
▢No
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APPENDIX D
Patient Satisfaction Survey

The
application
was easy to
set up
The
application
was easy to
use
The
application
Bluetooth was
helpful with
data
The
application
helped me
with checking
blood sugars
The
application
made it easy
to send blood
sugars to my
provider
The
application
helped me
track my diet &
exercise
Throughout
the project, I
was satisfied
with the
application
I will continue
to use the
application

Strongly
Agree
5

Agree

Undecided

Disagree

4

3

2

Strongly
Disagree
1

5

4

3

2

1

5

4

3

2

1

5

4

3

2

1

5

4

3

2

1

5

4

3

2

1

5

4

3

2

1

5

4

3

2

1
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APPENDIX E
Application Information Handout
Connecting your Smartphone to mySugr©
•

•

mySugr©, the application used in this project has Bluetooth capability. To connect your
device to your phone, follow these steps:
o On your mobile phone, turn Bluetooth ON and open mySugr©
o On your meter, make sure it is turned off. Press and hold
Ü Þ buttons at the same time until Bluetooth symbol appears. Both (Link) and
(volume) show on the screen and will flash.
o Find the 6-digit PIN on the back of your meter.
o On your mobile phone within the mySugr© application, follow the on-screen
instructions and select the meter that shows. When directed, enter the meter’s 6digit PIN (do this quickly, the meter will time out after 30 seconds).
o On the meter, your screen will either show OK if connection was successful or Err
if unsuccessful.
o If the Err message is shown, try the above steps again or contact the student
project leader at 608-852-3749.
Transferring Data
o If the meter is paired with the mySugr© app correctly as above, data will be sent
to the app automatically with no action needed.
o Note: turning off your smart phone Bluetooth connection will NOT unpair your
meter from the application.
§ If turning Bluetooth back on after having it off, follow these steps:
• With the meter off, press and hold Ü OR Þ buttons until the last
stored result appears on the screen
• Press and hold the (Power) button until the Bluetooth symbol
appears. Then proceed as you normally would to check your blood
sugar.

Creating a PDF report of your data:
• On your smart phone, open the mySugr© app
• On the bottom toolbar, click on the report button
• Once on report screen, you will see an option for file format. Click on this and a dropdown menu will appear. Slide through the options until you find PDF.
• You will then see a section titled period. This is referring to the time of blood glucose
readings. Selected the 2-week option.
• Then hit the export button. From here, a PDF form will generate and show on your
screen.
• If using APPLE PRODUCTS, click the button in the upper right-hand corner of your
screen that appears like an arrow. Scroll down the options menu until you see “save to
files”. Click this and save the report to “My downloads”.
• From here, open the “files” application on your iPhone. If you do not have it on your
screen, you can search for it in the search bar.
• Your downloaded report from mySugr© should appear here.
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•

Once the report is generated and you have located it, you can attach this PDF file into
your MyHealtheVet chart.
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APPENDIX F
IRB Training
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APPENDIX G
MyHealtheVet Informational Flyer
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Appendix H
Permission To Utilize DES-SF
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APPENDIX I
Diabetes Empowerment Scale- Short Form (DES-SF)
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APPENDIX J
Gantt Chart
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APPENDIX K
mySugr© Informational Handout

Download the mySugr app and send blood
glucose readings to your phone
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APPENDIX L
Evidence Table
Citation (APA)
Minooee, S. (2020).
SelfManagement/Selfcare: Interventions
Strategies. [Evidence
summary]. Joanna
Briggs Institute EBP
Database.
https://joannabriggs.or
g/

Purpose
Search for best
available
evidence
regarding
enhancing selfmanagement
or self-care for
individual with
chronic
disease

Sample
1 integrative
review, 3 RCTs, 4
systematic
reviews, 1
descriptive study,
1 cross sectional
study, 1
qualitative study

Design
Evidence
summary

Measurement
Self-care/ selfmanagement in
different groups of
patients with
chronic illnesses

Wu, Y., Yao, X.,
Vespasiani, G.,
Nicolucci, A., Dong,
Y., Kwong, J., Li., L.,
Sun, X., Tian, H., & Li,
S. (2017). Mobile appbased interventions to
support diabetes selfmanagement: A

Develop and
validate a
taxonomy of
apps for
diabetes selfmanagement,
perform a
meta-analysis
investigating

12 RCTs
involving appbased
interventions
involving 974
outpatients with
diabetes

Systematic
review

Evaluation of 96
diabetes mobile
apps with 5
management
modules
(monitoring,
medication
management,
lifestyle

Results/Findings
The most common
strategies were regular
medical reviews with
practitioners and
distribution of educational
material including videos,
exercise, and computer
programs
• Self-care behaviors were
lower in patients
uncontrolled chronic
disease
• Mobile phone messaging
interventions may provide
benefit in supporting selfmanagement of long-term
illness
• Educational sessions and
self-care management
plans in combination
should be used to assist
with self-care processes
(Minooee, 2020).
• The use of mobile appbased interventions was
associated with clinically
significant HbA1C
reduction of 0.48% (95%
CI, 0.19%-0.78%, I2=
76%, P<.001) compared
with standard of care
alone
•

LOE
Level I

Level I

70
systematic review of
randomized controlled
trials to identify
functions associated
with glycemic efficacy.
JMIR Mhealth
Uhealth, 5(3), e35.
https://doi.org/10.2196
/mhealth.6522

Manuel, B. (2020).
Diabetes
management: Using
ehealth in a rural or
remote setting.
[Evidence Summary].
Joanna Briggs
Institute EBP
Database.
https://joannabriggs.or
g/

the effects of
mobile appbased
interventions
on glycemic
control in
adults with
diabetes,
explore the
contribution of
different
functions to the
glycemic
efficacy of
entire appbased
interventions
using the
taxonomy and
subgroup
analysis (Wu,
2017).
Determine best
evidence for
remote
management
of T2DM

modifications,
complication
prevention,
psychosocial care)

•

•

•

•

5 systematic
reviews, 2 RCTs,
1 expert opinion

Evidence
summary

Effectiveness of
computer or mobile
phone-based
programs for
monitoring and
management of
diabetes

•

•

•

Larger HbA1C reductions
noted for patients with
T2DM (MD 0.67%, 95%
CI 0.30%-1.03%, I2=
47%, P=.11).
Having a structured
display was associated
with larger HbA1C
reduction
Interventions using
manual entry showed an
associated lower HbA1C
reduction without
statistical significance
“Direct data transmission
between users and
mobile devices using wire
or wireless connections
was associated with a
trend towards reduced
HbA1C”
Mobile phone-based
interventions have a
larger beneficial effect on
glycemic control for T2DM
patient’s vs computer
based
Mobile phone use in
monitoring and managing
T2DM improved HbA1C
levels and selfmanagement behaviors
Best practice
recommendation: “mobilebased support programs

Level I

71

•

Alexandre, K.,
Campbell, J., Bugnon,
M., Henry, C.,
Schaub, C., Serex, M.,
Elmers, J.,
Desrichard, O., &
PeytremannBridevaux, I. (2021).
Factors influencing
diabetes selfmanagement in
adults: An umbrella
review of systematic
reviews. JBI
systematic review,
19(5), 1003-1118.
https://10.11124/JBIE
S-20-00020

Identify and
describe
factors that
influence
diabetes selfmanagement
by
summarizing
the known
evidence

114 systematic
reviews

Systematic
review

Factors influencing
adult diabetes selfmanagement in
general or on
individual self-care
behaviors (taking
medications, selfmonitoring blood
glucose, healthy
eating, regular
exercise, smoking
cessation)

•

•

•

should be considered in
management of diabetic
patients where available”
(Manuel, 2020).
Best practice
recommendation:
“telephone follow-up
should be utilized in
diabetes management,
particularly in T2DM”
(Manuel, 2020).
The most frequent factors
influencing self-care
behavior (SCB) is
relationship with
healthcare professionals
(communication & shared
decision making),
knowledge about disease
and medication, social
support, and availability of
services
Positive influencing
factors: social support
from friends and family,
interventions led by health
professionals, knowledge
about the disease/
medication/ behaviors
associated with DSM, and
strong community
environment
Paying attention to both
individual DSM behaviors
(medication taking) and
overall DSM behaviors

Level I

72

•

•

Lizarondo, L. (2021).
Glycemic control in
diabetes: Telehealth
[Evidence Summary].
Joanna Briggs
Institute EBP
Database.
https://joannabriggs.or
g/

Best available
evidence for
the
effectiveness
of telehealth
for type 2
diabetes
management

7 systematic
reviews

Evidence
summary

HbA1c levels

•

•

(several self-care
behaviors at once) may
be beneficial
Knowledge about the
disease, motivation, and
self-efficacy, should all
constitute essential parts
of any intervention to
promote adult DSM
To best support DSM,
health professionals must
be interested in
understanding DSM in
broader context including
personal, interpersonal,
and environmental
characteristics
Pooled results indicated a
small but statistically
significant difference
between intervention and
comparator groups, in
favor of the intervention.
The impact of HbA1c was
greater in the mobile
phone subgroup
compared to other types
Mobile/ smartphone with
self-management apps:
pooled results
demonstrated a significant
reduction in HbA1c in
patients who received
intervention compared to
standard diabetes care.
When apps with feedback

Level I

73

Pal, K., Eastwood, S.
V., Michie, S., Farmer,
A. J., Barnard, M. L.,
Peacock, R., Wood,
B., Inniss, J. D. &
Murray, E. (2013).
Computer-based
diabetes selfmanagement
interventions for adults
with type 2 diabetes
mellitus (Review).
Cochrane Database of
Systematic Reviews.
https://doi.org/10.1002

“Assess the
effects on
health status
and healthrelated quality
of life of
computerbased diabetes
selfmanagement
interventions
for adults with
type 2 diabetes
mellitus” (p. 1).

16 RCTsincluding adult
patients over the
age of 18 with
type 2 diabetes
mellitus

Systematic
review

Impact of
computer-based
interventions on
HbA1C levels,
health-related
quality of life, and
change of
knowledge level for
type 2 diabetes
mellitus vs.
standard diabetes
care

and without feedback
were compared, the
reduction in HbA1c was
not statistically significant
for those who did not
receive feedback
• “patients with type 2
diabetes should be
offered telehealth as an
option for monitoring their
condition and accessing
self-management
education. The most
optimal type/approach,
functions, intensity and
frequency remains
unclear and should be
informed by clinical
expertise and individual
patient presentation”
• There is a small,
statistically significant
difference in outcomes
between intervention and
comparison groups of 2.3
mmol/mol or mean
difference (MD) -0.2%
(95% CI -0.4 to -0.1) for
HbA1C level for pooled
computer intervention
groups
• HbA1C impact was larger
in mobile phone
subgroups of -5.5
mmol/mol or -0.5% (95%
CI -0.7 to -0.3) and no

Level I

74
/14651858.CD008776
.pub2

The management of
type 2 diabetes
mellitus in primary
care work group
(2017). VA/DoD
clinical practice
guideline for
management of type 2
diabetes mellitus in

Discuss best
practice
guidelines for
the
management
of type 2
diabetes
mellitus

RCTs published
between 2009March 2016

Clinical
practice
guideline

N/A

heterogeneity. Computer
based groups had
smaller effect sizes and
was not statistically
significant: -1.5 mmol/mol
or -0.1% (95% CI -0.3 to
0.1).
• Looking at mobile phonebased interventions, all of
these interventions
provided feedback on
performance and
provided prompts or cues
for desired behavior
change around blood
glucose self-monitoring.
This subgroup was
associated with larger
improvement in HbA1C
than other interventions
• Five studies examined
health-related quality of
life but there was no
evidence to show any
significant improvement
with computer-based
interventions
• Recommended to offer
one or more types of
bidirectional interventions
(computer, telephone, or
other electronic means)
involving licensed
independent practitioners
to patients selected by
their primary care provider

Level I

75
primary care.
Department of
Veterans Affairs,
Department of
Defense.
https://web.archive.org
/web/2018061008005
8/https://www.healthq
uality.va.gov/guideline
s/CD/diabetes/VADoD
DMCPGFinal508.pdf

•

•

Aminuddin, H. B.,
Jaio, N., Jiang, Y.,
Hong, J., & Wang, W.
(2019). Effectiveness
of smartphone-based
self-management
interventions on selfefficacy, self-care
activities, healthrelated quality of life
and clinical outcomes
in patients with type 2
diabetes: A systematic

Determine
effectiveness
of smartphonebased mobile
applications on
HbA1C, selfcare activities,
and selfefficacy

22 RCTs

Systematic
review & metaanalysis

HbA1c, self-care
activities, selfefficacy

•

•

as an adjunct to usual
care
“Improvements were seen
in HbA1C when patients
had the ability to upload
glucose monitoring device
data for review by the RN
case manager or provider.
Dedication of this
resource to high-risk
elevated HbA1C
populations may help
control outcomes where
utilized” (p. 27).
Recommended to set a
HbA1C target range
based on absolute risk
reduction of significant
microvascular
complications, life
expectancy, patient
preferences and social
determinants of health
Pooled studies that used
smartphone interventions
were found to be
significant in improving
self-efficacy with a large
effect size (d= 0.39; 95%
CI 0.16 to 0.61; P<0.001)
Pooled studies evaluating
self-care activities using
smartphone applications
were found to be
statistically significant (d=

Level I

76
review and metaanalysis. International
Journal of Nursing
Studies, 116, 1-10.
https://doi.org/10.1016
/j.ijnurstu.2019.02.003

•

•

•

Wang, Y., Li, M.,
Zhao, X., Pan, X., Lu,
M., Lu, J., & Hu, Y.
(2019). Effects of
continuous care for
patients with type 2
diabetes using mobile
health application: A
randomized controlled
trial. Int J Health Plann
Management, 34,
1025-1035.

Determine
clinical effect
of continuous
care for
patients with
type 2 diabetes
using mobile
health
application

120 patients with
type 2 diabetes
(intervention:
n=60, control:
n=60)

RCT

HbA1c levels,
blood glucose
levels, self-care
abilities

•

•

0.90; 95% CI 0.24 to 1.57;
P<0.001)
The effect of smartphonebased interventions on
reduction of HbA1C was
statistically significant
(pooled MD= -0.55; 95%
CI -0.60 to -0.40;
P<0.001)
Participants with HbA1C
of <8% at baseline
showed larger
improvements in selfefficacy
“Smartphone-based
interventions have the
advantage of being easy
to use and widely
accessible, and thus can
keep patients engaged
longer, increasing
effectiveness on self-care
activities” (p. 8)
Self-management was
found to be higher in the
test group than in the
control group after 6month period (P>.05)
“The use of the mobile
health application system
can promote knowledge
of self-monitoring of blood
sugar, eating habits
report, blood sugar
control, and monitoring

Level II

77
https://doi.org/10.1002
/hpm.2872
•

•

•

Yoshida, Y., Boren,
S., Soares, J.,
Popescu, M., Nielson,
S. D., & Simoes, E. J.
(2018). Effect of
health information
technologies on
glycemic control
among patients with
type 2 diabetes.
Current Diabetes

Present
findings of the
effect of health
information
technologies
(HITs) on
glycemic
control among
patients with
type 2 diabetes

34 RCTs included
in the metaanalysis

Meta-analysis

HbA1c levels
based on mobile,
computer-based, email, and internet
interventions

•

•

frequency and accuracy”
(p. 1032)
Blood glucose and
HbA1C levels were
statistically significant and
lower in the test group
compared to the control
group (P < .05)
“This study revealed that
continuous care based on
mobile service platform
significantly lowered
patients’ blood glucose
levels” (p. 1032)
“Continuous care
provided through a mobile
phone application for
patients with type 2
diabetes significantly
improved patient cognition
levels and selfmanagement abilities,
thereby reducing patients’
blood glucose levels” (p.
1034).
The standardized mean
reduction in HbA1C
resulting from HITs was 0.57 (95% CI -0.71, -0.43)
with values ranging from 2.10 to -0.01.
The pooled standardized
decreases in Hba1c for
mobile-based applications
was -0.67 (-0.90, -0.45)

Level I

78
•

Reports, 18, 130.
https://doi.org/10.1007
/s11892-018-1105-2

•

Wu, X., Guo, X., &
Zhang, Z. (2019). The
efficacy of mobile
phone apps for
lifestyle modification in
diabetes: Systematic
review and metaanalysis. JMIR
Mhealth Uhealth, 7(1),
1-23.
https://doi.org/10.2196
/12297

Summarize
and synthesize
evidence of
mobile phone
apps for
lifestyle
changes in
subtypes of
diabetes

23 RCTs

Systematic
review & metaanalysis

Primary outcome:
HbA1c

•

Secondary
outcomes:
behavioral changes
with diet & exercise
•

•
•

“Findings from this metaanalysis suggest that
HITs lead to improvement
in glycemic control, both
clinically and statistically”
(p. 5)
“Among all technology
features under review, we
found mobile phonebased and SMS/text
approaches to be
particularly effective in
improving glycemic
profile” (p. 8)
Overall difference for
short-term effect in HbA1c
between app intervention
and control groups -0.48
(95% CI -0.69 to -0.28)
which was significantly
different from 0 (P<.01)
Overall difference for
long-term effect subgroup
HbA1c of -0.25 (95% CI 0.43 to -0.07), (P<.01)
Long-erm and short-term
effects were both
significant
“the results of our review
indicate that there is
strong evidence for
efficacy of apps for
lifestyle modification in
T2DM” (p. 16).

Level I

79
Hou, C., Xu, Q., Diao,
S., Hewitt, J., Li, J., &
Carter, B. (2018).
Mobile phone
applications and selfmanagement of
diabetes: A systematic
review and metaanalysis, metaregression of 21
randomized trials and
GRADE. Diabetes,
Obesity and
Metabolism: A Journal
of Pharmacology and
Therapeutics, 20,
2009-2013.
https://doi.org/10.1111
/dom.13307

Update the
evidence of
diabetes apps
to improve
glycemic
control and
selfmanagement
for diabetes

Hou, C., Carter, B.,
Hewitt, J., Francisa,
T., & Mayor, S.
(2016). Do mobile
phone applications
improve glycemic
control (HbA1c) in the
self-management of
diabetes? A
systematic review,
meta-analysis, and
GRADE of 14
randomized trials.
Diabetes Care, 39,
2089-2095.

Investigate
effect of mobile
health apps on
glycemic
control in selfmanagement
of diabetes

21 RCTs

Systematic
review & metaanalysis

HbA1c levels,
effect of HCP
feedback on HbA1c
level

•

•

•

14 RCTs

Systematic
review & metaanalysis

HbA1c levels

•
•

Diabetes apps were
associated with mean
reduction of 0.57% in
hbA1c (95% CI, 0.320.82; P<.01)
Studies with no HCP
feedback had a mean
HbA1C reduction of
0.24% (95% CI, -0.02 to
0.49) whereas this
increased in studies with
low and high feedback to
0.33% (95% CI, 0.070.59) and 1.12% (95% CI,
0.91-1.32)
“Results overall reaffirmed
that apps for T2DM help
with self-management,
but also demonstrated a
HCP dose-response with
HbA1C” (p. 2010).
Mean reduction in Hba1c
was 0.49% (95% CI 0.30
to 0.68; P<0.01)
Studies of younger
participants (less than or
equal to 55y/o) reported
larger and clinically
significant reduction in
HbA1C level of 1.03%
compared with 0.41% in
those with average age
>55y/o but result was not
found to be statistically
significant (P=0.10)

Level I

Level I

80
•

https://doi.org/10.2337
/dc16-0346

Cui, M., Wu, X., Mao,
J., Wang, X., & Nie,
M. (2016). T2DM selfmanagement via
smartphone
applications: A
systematic review and
meta-analysis. PLoS
ONE, 11(11), 1-15.
https://doi.org/10.1371
/journal.pone.0166718

Review RCTs
to assess
effect of
mHealth apps
on changes in
HbA1C, blood
glucose, blood
pressure,
serum lipids,
and body
weight in type
2 diabetes
mellitus
patients

13 RCTs

Systematic
review & metaanalysis

HbA1c levels

•

•

•

•

•

“the results of metaanalysis lend support to
the use of diabetes apps
in diabetes selfmanagement, especially
for type 2 diabetes” (p.
2093).
Mobile phone app
strategies were
associated with significant
reduction in HbA1c by 0.40% (95% CI -0.69 to 0.11%; p=0.007)
mHelath with feedback:
overall effect size for
HbA1c was statistically
significant -0.40% (95%
CI -0.69 to -0.11%;
p=0.008)
mHealth without
feedback, effect size was
larger but no longer
statistically significant 0.46% (95% CI -1.19 to
0.26%; p=0.21).
mobilephone/smartphone-based
self-management apps
appear to have moderate
benefit on glycemic
control with a pooled
effect on HbA1C
reduction of -0.40%
patients with milder
disease with baseline
levels of HbA1c lower

Level I

81
than 8% appeared to
benefit more from
mHealth apps compared
to those with higher
baseline HbA1c

